Molecular defects in chronic myeloproliferative disorders

被引:7
作者
Albitar, M [1 ]
Freireich, EJ [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
D O I
10.1007/BF03401794
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:555 / 567
页数:13
相关论文
共 121 条
[91]   Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: A case report [J].
Savasan, S ;
Zulfikar, B ;
Ozgeneci, A ;
Ozbek, U ;
Sengun, Z .
JOURNAL OF CHEMOTHERAPY, 1996, 8 (03) :243-246
[92]   CHRONIC MYELOMONOCYTIC LEUKEMIA - TEL-A-KINASE WHAT ETS ALL ABOUT [J].
SAWYERS, CL ;
DENNY, CT .
CELL, 1994, 77 (02) :171-173
[93]  
SCHREZENMEIER H, 1993, EXP HEMATOL, V21, P358
[94]  
SHANNON KM, 1992, BLOOD, V79, P1311
[95]   A near-haploid bone marrow karyotype in systemic mast cell disease: Is it characteristic of the disease or an incidental finding? [J].
Shekhter-Levin, S ;
Ball, E ;
Swerdlow, SH ;
Li, WV ;
Kapadia, SB ;
Sherer, ME ;
Wald, N ;
Gollin, SM .
CANCER GENETICS AND CYTOGENETICS, 1998, 103 (02) :124-129
[96]   HOMOZYGOUS DELETIONS OF THE P16 TUMOR-SUPPRESSOR GENE ARE ASSOCIATED WITH LYMPHOID TRANSFORMATION OF CHRONIC MYELOID-LEUKEMIA [J].
SILL, H ;
GOLDMAN, JM ;
CROSS, NCP .
BLOOD, 1995, 85 (08) :2013-2016
[97]   CYTOGENETIC STUDIES IN 12 PATIENTS WITH PRIMARY MYELOFIBROSIS AND MYELOID METAPLASIA [J].
SMADJA, N ;
KRULIK, M ;
DEGRAMONT, A ;
SIRINELLI, A ;
BRISSAUD, P ;
DRAY, C ;
AUDEBERT, AA ;
DEBRAY, J .
CANCER GENETICS AND CYTOGENETICS, 1987, 24 (01) :151-158
[98]  
STRATH M, 1992, EXP HEMATOL, V20, P229
[99]   Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L [J].
Taksin, AL ;
Le Couedic, JP ;
Dusanter-Fourt, I ;
Massé, A ;
Giraudier, S ;
Katz, A ;
Wendling, F ;
Vainchenker, W ;
Casadevall, N ;
Debili, N .
BLOOD, 1999, 93 (01) :125-139
[100]  
Tefferi A, 1999, SEMIN HEMATOL, V36, P1